Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial

OBJECTIVES: The aim of this study is to evaluate the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in hospitalized adults with severe SARS-CoV-2 infection. TRIAL DESIGN: This is a prospective, single-center, phase 2, randomized, controlled trial that is blinded to participants and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Trials
Main Authors: Eckhardt, Christina M., Cummings, Matthew J., Rajagopalan, Kartik N., Borden, Sarah, Bitan, Zachary C., Wolf, Allison, Kantor, Alex, Briese, Thomas, Meyer, Benjamin J., Jacobson, Samuel D., Scotto, Dawn, Mishra, Nischay, Philip, Neena M., Stotler, Brie A., Schwartz, Joseph, Shaz, Beth, Spitalnik, Steven L., Eisenberg, Andrew, Hod, Eldad A., Justman, Jessica, Cheung, Ken, Lipkin, W. Ian, O’Donnell, Max R.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Letter
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7276974/
https://ncbi.nlm.nih.gov/pubmed/32513308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04422-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados